U.K. Clinical Trial Supply & Logistics Market Size & Outlook
The clinical trial supply & logistics market in the UK is expected to reach a projected revenue of US$ 432.1 million by 2030. A compound annual growth rate of 7.5% is expected of the UK clinical trial supply & logistics market from 2024 to 2030.
In terms of revenue, UK accounted for 6.9% of the global clinical trial supply & logistics market in 2023.
Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
In Europe, Germany clinical trial supply & logistics market is projected to lead the regional market in terms of revenue in 2030.
Italy is the fastest growing regional market in Europe and is projected to reach USD 194.5 million by 2030.
UK is the biggest and a major hub for biopharmaceutical companies. It has players such as AstraZeneca, Novartis, and GlaxoSmithKline plc. Major quantity of supplies is transported from the UK to various parts of Europe.
For instance, major clinical supply service players such as DHL, PCI, Alamac, Fisher Clinical, and Catalent have distribution and packaging centers in the UK, which provide services across Europe. The only challenge is that there is a lot of ambiguity in terms of regulations, as it concerns supply and logistics centers in this country.
U.K. Clinical Trial Supply & Logistics Market Outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Clinical Trial Supply & Logistics Market Outlook will help companies and investors design strategic landscapes.
Logistics & Distribution was the largest segment with a revenue share of 25.33% in 2023.
Horizon Databook has segmented the U.K. clinical trial supply & logistics market based on logistics & distribution, storage & retention, packaging, labeling and blinding, manufacturing, comparator sourcing, other services (solutions, ancillary supply) covering the revenue growth of each sub-segment from 2018 to 2030.
UK is the biggest and a major hub for biopharmaceutical companies. It has players such as AstraZeneca, Novartis, and GlaxoSmithKline plc. Major quantity of supplies is transported from the UK to various parts of Europe.
For instance, major clinical supply service players such as DHL, PCI, Alamac, Fisher Clinical, and Catalent have distribution and packaging centers in the UK, which provide services across Europe. The only challenge is that there is a lot of ambiguity in terms of regulations, as it concerns supply and logistics centers in this country.
U.K. Clinical Trial Supply & Logistics Market Service Outlook (Revenue, USD Million , 2018-2030)
Logistics & distribution
Storage & retention
Packaging, labeling and blinding
Manufacturing
Comparator sourcing
Other services (solutions, ancillary supply)
U.K. Clinical Trial Supply & Logistics Market End User Outlook (Revenue, USD Million , 2018-2030)
Pharmaceuticals
Biologicals
Medical Device
U.K. Clinical Trial Supply & Logistics Market Therapeutic Areas Outlook (Revenue, USD Million , 2018-2030)
Oncology
Cardiovascular Diseases
Respiratory Diseases
CNS And Mental Disorders
Others
U.K. Clinical Trial Supply & Logistics Market Phase Outlook (Revenue, USD Million , 2018-2030)
Phase I
Phase II
Phase III
Phase IV
Reasons to subscribe to Clinical Trial Supply & Logistics Market Outlook databook
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Clinical Trial Supply & Logistics Market Outlook databook
Our clientele includes a mix of Clinical Trial Supply & Logistics Market Outlook companies, investment firms, advisory firms & academic institutions.
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the U.K. Clinical Trial Supply & Logistics Market Outlook, including forecasts for subscribers. This country databook contains high-level insights into U.K. Clinical Trial Supply & Logistics Market Outlook from 2018 to 2030, including revenue numbers, major trends, and company profiles.